BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11447384)

  • 1. The role of the C-C chemokine receptor-5 Delta32 polymorphism in asthma and in the production of regulated on activation, normal T cells expressed and secreted.
    Sandford AJ; Zhu S; Bai TR; Fitzgerald JM; Paré PD
    J Allergy Clin Immunol; 2001 Jul; 108(1):69-73. PubMed ID: 11447384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis.
    Pokorny V; McQueen F; Yeoman S; Merriman M; Merriman A; Harrison A; Highton J; McLean L
    Ann Rheum Dis; 2005 Mar; 64(3):487-90. PubMed ID: 15331395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-24, RANTES and CCR5 gene polymorphisms are not associated with chronic adult periodontitis.
    Savarrio L; Donati M; Carr C; Kinane DF; Berglundh T
    J Periodontal Res; 2007 Apr; 42(2):152-8. PubMed ID: 17305874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polymorphism of regulated upon activation, normal T cell expressed and secreted promoter region -28 position in Chinese allergic asthmatic children].
    Wang LJ; Li YR; Chen JH; Cui TP; Wu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):394-7. PubMed ID: 15256089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
    Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
    Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between RANTES polymorphisms and asthma severity among Tunisian children.
    Lachheb J; Chelbi H; Hamzaoui K; Hamzaoui A
    Hum Immunol; 2007 Aug; 68(8):675-80. PubMed ID: 17678722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.
    Sandford B; Bown M; London N; Sayers R
    Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis.
    Zhou Y; Huang D; Farver C; Hoffman GS
    J Rheumatol; 2003 Jul; 30(7):1541-7. PubMed ID: 12858455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CCR5-delta32 mutation with reduced risk of nonatopic asthma in Slovenian children.
    Berce V; Repnik K; Potocnik U
    J Asthma; 2008 Nov; 45(9):780-4. PubMed ID: 18972295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 plays a pivotal role in LFA-1-mediated T cell adhesiveness by up-regulation of CCR5 expression.
    Mukai T; Iwasaki M; Gao P; Tomura M; Yashiro-Ohtani Y; Ono S; Murai M; Matsushima K; Kurimoto M; Kogo M; Matsuya T; Fujiwara H; Hamaoka T
    J Leukoc Biol; 2001 Sep; 70(3):422-30. PubMed ID: 11527992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis.
    Mack M; Brühl H; Gruber R; Jaeger C; Cihak J; Eiter V; Plachý J; Stangassinger M; Uhlig K; Schattenkirchner M; Schlöndorff D
    Arthritis Rheum; 1999 May; 42(5):981-8. PubMed ID: 10323454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant responsiveness to RANTES in synovial fluid T cells from patients with rheumatoid arthritis.
    Hisakawa N; Tanaka H; Hosono O; Nishijima R; Ohashi Y; Saito S; Nishiya K; Hashimoto K; Morimoto C
    J Rheumatol; 2002 Jun; 29(6):1124-34. PubMed ID: 12064824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.
    Melum E; Karlsen TH; Broomé U; Thorsby E; Schrumpf E; Boberg KM; Lie BA
    Tissue Antigens; 2006 Jul; 68(1):78-81. PubMed ID: 16774544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
    Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF
    J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis.
    Brajão de Oliveira K; Reiche EM; Kaminami Morimoto H; Pelegrinelli Fungaro MH; Estevão D; Pontello R; Franco Nasser T; Watanabe MA
    J Cutan Pathol; 2007 Jan; 34(1):27-32. PubMed ID: 17214851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis.
    Badewa AP; Quinton LJ; Shellito JE; Mason CM
    Tuberculosis (Edinb); 2005 May; 85(3):185-95. PubMed ID: 15850756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of RANTES and T-cell apoptosis in human renal allograft.
    Racca A; Bailat A; García MI; Soutullo A; Gaite L; Malan Borel I
    Scand J Immunol; 2005 Feb; 61(2):157-64. PubMed ID: 15683452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.